Live Breaking News & Updates on Intarcia Therapeutics

Stay updated with breaking news from Intarcia therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SeaStar Medical Appoints David A. Green as Chief Financial Officer

SeaStar Medical Appoints David A. Green as Chief Financial Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , New York , University Of Rochester , Aytu Biopharma , Prolacta Bioscience , Eric Schlorff , Caryl Baron , Jody Cain , Duff Phelps , Ernst Young Palo Alto Center , Seastar Medical Holding Corporation Nasdaq , University Of New York , Specialized Health Products International , Star Medical Holding Corporation , Chief Financial Officer , Seastar Medical , Vice President , Selected Cytopheretic Device Pediatric , Star Medical , Executive Vice President , Chief Accounting Officer , Intarcia Therapeutics , Catheter Connections , Merit Medical , Managing Director , Palo Alto Center ,

C4 Therapeutics Inc. (CCCC) Appoints Owen Hughes to its Board

C4 Therapeutics Inc. (CCCC) Appoints Owen Hughes to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Rowen Hughes , Bruce Downey , Radius Health , Therapeutics Inc , Dartmouth College , Fidelity Investments , Cullinan Oncology , Intarcia Therapeutics , Wall Street , Brookside Capital , Bain Capital , Pyramis Advisors , Sail Bio , Gurnet Point Capital , Translate Bio ,

FDA committee unanimously rejects GLP-1 implant for type 2 diabetes

FDA committee unanimously rejects GLP-1 implant for type 2 diabetes
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Patrickh Nachman , Robert Greevy , Bydureon Byetta , Connieb Newman , Jill Rollet , University Of Minnesota , York University School Of Medicine , Vanderbilt University , Endocrinologic Metabolic Drugs Advisory Committee , Metabolic Drugs Advisory Committee , Metabolic Drugs Advisory , Intarcia Therapeutics , New York University School ,

FDA Panel Rejects Implanted GLP1-RA-Dosing Device for T2D

An implanted device for delivering the GLP-1 receptor agonist exenatide to people with type 2 diabetes received a unanimous no vote from an FDA advisory panel based on safety and other concerns. ....

United States , Erica Brittain , University Of Colorado Hospital , Metabolic Drugs Advisory Committee , Glucose Management Team , Drug Administration , Intarcia Therapeutics , Biostatistics Research Branch , National Institute , Infectious Diseases , Metabolic Drugs Advisory , Flow Wang , Diabetes Mellitus Type 2 , Iabetes Mellitus Type Ii , Type 2 Diabetes , Glp 1 Receptor Agonists , Glucagon Like Peptide 1 Receptor Agonists , Acute Kidney Injury Aki , Acute Kidney Injury , Renal Failure , Enal Insufficiency , Idney Insufficiency , Kidney Failure , Dherence To Medication Issues For Patients , Prostate Carcinoma , Alignant Prostate Neoplasm ,

FDA advisers discuss twice-rejected diabetes drug implant

FDA panel is gathering Sept. 21 to discuss ITCA 650, a Type 2 diabetes drug delivery product under review for possible approval. The experimental therapy has been denied approval twice. ....

United States , Metabolic Drugs Advisory Committee , Intarcia Therapeutics , Tca 650 , Type 2 Diabetes , Drug Delivery , Intarcia Therapeutics , Glp 1 ,